The Effect of the Inclusion of Soybean Flour on Glycemic Responses
Key facts
- Who runs it
- University of Illinois at Urbana-Champaign
- Where
- Champaign, United StatesSee the site
- Trial code
- Status
- Terminated
- People taking part
- 17 people enrolled
- Started
- 11 Mar 2024
- Ended
- 20 Jun 2025
- Type of study
- Interventional, 3 groups
- Treatments tested
- Replacement of wheat flour by soyflour
- Record updated
- 6 August 2025
- Why it stopped
- We recruited and completed all 3 interventions in 10 participants for bread and 10 for tortilla, but stopped at 8 participants (instead of 10) for arepa and two of these participants only completed 2 out of 3 interventions because funding end.
Who can take part
- Age
- 21 years to 45 years
- Sex
- Women and men
- Healthy volunteers
- Can take part
The registry criteria, word for word
Show all 19 criteriaShow less
Who can take part
- Male and female between 21-45 years of age
- All races/ethnicities
- Body mass Index (BMI) > 25 kg/m2 and <40 kg/m2 (i.e., overweight and obesity, excluding severe obesity)
- Fat %: > 30% for female or > 20% for male
Who cannot take part
- Gluten intolerance (Gluten allergy, wheat allergy, celiac disease), Soy intolerance or allergy
- Presence of malabsorption syndrome
- History of bariatric surgery
- Presence of inflammatory intestinal disease, liver, or kidney disease
- Polycystic ovary syndrome (pcos)
- Untreated hypertension
- Seizures
- Hemoglobin: <11g/dl for female and <13g/dl for male
- Diabetes (fasting glucose level >126mg/dl or plasma glucose level 2h after glucose challenge >200 mg/dl) or taking medicines to treat diabetes
- Taking any medication that might affect glucose metabolism or the results of our study
- History of cancer <5 years ago
- Currently smokes or quit smoking nicotine cigarettes, vapes or E-cigarettes for less than 6 months ago
- Pregnant, breastfeeding, menopausal
- Blood donation in the past 8 weeks
- Abnormalities in the metabolic panel test (e.g., liver enzymes >2 times the upper limit)
Where in United States
- University of Illinois at Urbana-ChampaignChampaign, United States
About the trial
What the trial wants to find out
Foods that release glucose rapidly, leading to spikes in blood sugar and insulin (known as high glycemic index foods), generate lower satiety responses than foods with low glycemic index. High glycemic index foods are also linked to an increased risk of developing diabetes. The partial replacement of carbohydrates in rich staple foods with soy flour has the potential to reduce glycemic response and improve satiety.
Read full original descriptionShow less
In many regions of Latin America, as well as in the Middle East and North Africa (MENA) regions, bread is the staple source of calories, but it is a relatively poor source of balanced nutrition. Bread enriched with soy flour could provide higher dietary protein while moderating blood glucose (and insulin) spikes, which can help reduce insulin resistance and metabolic diseases. The results of this study could provide government and private human nutritionists with the evidence they need to formulate soy flour into bread, corn tortillas, and arepas for schools and homes.
The 3 groups in the trial
- BreadTreatment being tested
Bread will be prepared with 100 % of wheat flour and with some replacements by different % of soy flour (at three concentrations)
Treatment: Replacement of wheat flour by soyflour
- TortillaTreatment being tested
Bread will be prepared with 100 % of wheat flour and with some replacements by different % of soy flour (at three concentrations)
Treatment: Replacement of wheat flour by soyflour
- ArepaTreatment being tested
Arepa will be prepared with 100 % of wheat flour and with some replacements by different % of soy flour (at three concentrations)
Treatment: Replacement of wheat flour by soyflour
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- The Effect of the Inclusion of Soybean Flour on Glycemic Responses of Bread, Tortilla, and Arepa to Enhance Human Nutrition
- Record updated
- 6 August 2025